Kanamycin
Pharmaceutical forms
Injection
Country lists
ATC N/A
Composition 50 mg (sulfate)/mL in ampoule
Observations for this pharmaceutical form can be found on the lists:
Cuba
6.2.3 Aminoglucósidos
  • No observations
Powder for injection
Country lists
ATC N/A
Composition 1g
Observations for this pharmaceutical form can be found on the lists:
Chile
Essential and Prioritized Medications
  • No observations
Powder for injection
Country lists
ATC N/A
Composition 1 g (as sulfate) in vial
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • Others observations:
    Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.  
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • No observations
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
6.2.4 Anti-Tuberculosis
  • No observations
Injection
Country lists
ATC N/A
Composition 200 mg (sulfate)/mL in vial
Observations for this pharmaceutical form can be found on the lists:
Cuba
6.2.3 Aminoglucósidos
  • No observations